touchPODCAST

The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials

touchEXPERT OPINIONS for touchHAEMATOLOGY

Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.  

The experts

• Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
• Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
• Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 
https://touchhaematologyime.org/eo-in-rrmm 

The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials

touchEXPERT OPINIONS for touchONCOLOGY

Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.  

The experts

• Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
• Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
• Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 
https://touchoncologyime.org/eo-in-rrmm

Diagnosing and treating patients with EoE: Tackling the difficulties

touchEXPERT OPINIONS for touchIMMUNOLOGY

Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.

The experts:

• Dr Efrem Eren, Southampton General Hospital, UK
• Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USA
• Dr Jamal Hayat, St George's University Hospitals NHS Trust, London, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME. 

For further information visit: https://touchimmunology.org/eoe-diagnosis-treatment

Diagnosing and treating patients with EoE: Tackling the difficulties

touchEXPERT OPINIONS for touchRESPIRATORY

Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.

The experts:

• Dr Efrem Eren, Southampton General Hospital, UK
• Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USA
• Dr Jamal Hayat, St George's University Hospitals NHS Trust, London, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME. 

For further information visit: https://touchrespiratoryime.org/eoe-diagnosis-treatment

touchMDT – Patient-centric care for prurigo nodularis – Discussion 3

touchMDT for touchIMMUNOLOGY

Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany
• Dermatologist: Dr Manuel Pereira, Berlin, Germany
• Psychodermatologist: Prof. Anthony Bewley, London, UK
• Patient advocate: Ms Sailaja Maganti, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/

touchMDT – Management of prurigo nodularis – Discussion 2

touchMDT for touchIMMUNOLOGY

Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany
• Dermatologist: Dr Manuel Pereira, Berlin, Germany
• Psychodermatologist: Prof. Anthony Bewley, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/

touchMDT – Burden of prurigo nodularis – Discussion 1

touchMDT for touchIMMUNOLOGY

Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany
• Dermatologist: Dr Manuel Pereira, Berlin, Germany
• Psychodermatologist: Prof. Anthony Bewley, London, UK
• Patient advocate: Ms Sailaja Maganti, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/

touchMDT – Patient-centric care for prurigo nodularis – Discussion 3

touchMDT for touchDERMATOLOGY

Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany
• Dermatologist: Dr Manuel Pereira, Berlin, Germany
• Psychodermatologist: Prof. Anthony Bewley, London, UK
• Patient advocate: Ms Sailaja Maganti, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//

touchMDT – Management of prurigo nodularis – Discussion 2

touchMDT for touchDERMATOLOGY

Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany
• Dermatologist: Dr Manuel Pereira, Berlin, Germany
• Psychodermatologist: Prof. Anthony Bewley, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//

touchMDT – Burden of prurigo nodularis – Discussion 1

touchMDT for touchDERMATOLOGY

Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany
• Dermatologist: Dr Manuel Pereira, Berlin, Germany
• Psychodermatologist: Prof. Anthony Bewley, London, UK
• Patient advocate: Ms Sailaja Maganti, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//